Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells Tetsuro KikuchiYasuharu AkasakiTsuneya Ohno Original Article 06 July 2001 Pages: 337 - 344
ALVAC-mediated gene transfer is efficient in lymphoid malignancies of T-and early B-cell origin, but not in tumors arising from mature B-cells Elena GitelsonAbhijit GhoseNeil L. Berinstein Original Article 14 August 2001 Pages: 345 - 355
Long-term tumor growth suppression in mice immunized with naked DNA of the human tumor antigen mucin (MUC1) Heiko JohnenHagen KulbeGabriele Pecher Original Article 09 August 2001 Pages: 356 - 360
IgG-recognizing shed tumor-associated antigens can promote tumor invasion and metastasis Julie K. NyhusChris C. WolfordEmilio Barbera-Guillem Original Article 09 August 2001 Pages: 361 - 372
Phase 1 clinical trial of irradiated autologous melanoma cells adenovirally transduced with human GM-CSF gene Masahiro KusumotoShuyo UmedaTsuneo Suzuki Original Article 14 August 2001 Pages: 373 - 381
Multiple myeloma cells are killed by syndecan-1-directed superantigen-activated T cells Lotten RagnarssonThomas StrömbergCecilia Weigelt Original Article 17 August 2001 Pages: 382 - 390